HomeTagsQIAGEN's blood-based

QIAGEN's blood-based

Biotechnology

Neuron23 and QIAGEN Announce Collaboration to Develop the Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

PR Newswire - September 15, 2022

Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, and QIAGEN ( NYSE: QGEN;...

Hot Topics

What Is Multimodal Transportation? A Guide for Modern Supply Chains

BAE Systems Launches Rapid Capability Kits Installations for U.S. Defense

Destinus acquires Daedalean to strengthen AI for Autonomous Flight